Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Nitric Oxide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Beyond Cancer Receives Approval for Phase 1b Trial
    Beyond Cancer Receives Approval for Phase 1b Trial

    03 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/03/2991054/0/en/Beyond-Cancer-Announces-Approval-by-the-Israeli-Ministry-of-Health-to-Conduct-a-Phase-1b-Clinical-Trial-Utilizing-Low-Volume-Ultra-High-Concentration-Nitric-Oxide-LV-UNO-in-Combina.html

    GLOBENEWSWIRE
    03 Dec 2024
    Share Share
    Beyond Cancer Presents Preclinical LV UNO Therapy Data at SITC
    Beyond Cancer Presents Preclinical LV UNO Therapy Data at SITC

    11 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/11/2978200/0/en/Beyond-Cancer-Presents-Promising-Preclinical-Data-on-Low-Volume-Ultra-High-Concentration-Nitric-Oxide-LV-UNO-Therapy-at-the-2024-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Mee.html

    GLOBENEWSWIRE
    11 Nov 2024
    Share Share
    Beyond Air® Schedules Q2 2025 Results Call and Webcast
    Beyond Air® Schedules Q2 2025 Results Call and Webcast

    29 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/29/2971253/0/en/Beyond-Air-Schedules-Second-Fiscal-Quarter-2025-Financial-Results-Conference-Call-and-Webcast.html

    GLOBENEWSWIRE
    29 Oct 2024
    Share Share
    Mallinckrodt Expands INOmax EVOLVE DS System In US Hospitals
    Mallinckrodt Expands INOmax EVOLVE DS System In US Hospitals

    10 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mallinckrodt-announces-an-expanded-rollout-of-the-inomax-evolve-ds-delivery-system-in-us-hospitals-302271897.html

    PR NEWSWIRE
    10 Oct 2024
    Share Share
    Beyond Cancer To Present UNO Therapy Data At SITC 2024
    Beyond Cancer To Present UNO Therapy Data At SITC 2024

    07 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/07/2958798/0/en/Beyond-Cancer-to-Present-Preclinical-Data-of-Ultra-High-Concentration-Nitric-Oxide-UNO-Low-Volume-Therapy-at-the-2024-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html

    GLOBENEWSWIRE
    07 Oct 2024
    Share Share
    Beyond Air Partners to Expand LungFit® PH Access
    Beyond Air Partners to Expand LungFit® PH Access

    02 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//en/news-release/2024/10/02/2956847/0/en/Beyond-Air-Partners-with-Healthcare-Links-to-Expand-Access-to-LungFit-PH-System-Through-Group-Purchasing-Organizations-and-Integrated-Delivery-Networks.html

    GLOBENEWSWIRE
    02 Oct 2024
    Share Share